Refinement and Assessment of New Magnetic Resonance Imaging (MRI) Technologies for Vascular, Abdominal, and Pelvic Exams
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- University of Michigan
- Enrollment
- 20
- Locations
- 1
- Primary Endpoint
- Evaluation of new software in MRI vascular imaging
Study Overview
Brief Summary
This study is being done to assess new Magnetic Resonance Imaging (MRI) technologies designed to improve MRI examinations of the vascular structures, abdomen, and pelvis regions.
Detailed Description
This study is being done to assess new Magnetic Resonance Imaging (MRI) technologies such as new hardware or software designed to improve MRI examinations of the vascular structures, abdomen, and pelvis regions. Software and hardware are always being improved, new machines replace old machines, software is updated and improved as well as devices used to produce better MRI images.
Study Design
- Study Type
- Interventional
- Allocation
- Na
- Intervention Model
- Single Group
- Primary Purpose
- Diagnostic
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •male or non-pregnant female patient
- •18 years or older
- •any ethnic background
- •presenting to MRI for a clinically-ordered chest MRI exam.
Exclusion Criteria
- •Patients, who have electrically, magnetically or mechanically activated implants such as heart pacemaker, magnetic surgical clips, prostheses or implanted neurological stimulator.
- •Pregnant patients or patients who are lactating.
- •A patient who is claustrophobic
Arms & Interventions
New MRI techniques
New hardware or software technologies designed to improve MRI (Magnetic Resonance Imaging) exams.
Intervention: MRI Magnetic Resonance Imaging (Procedure)
Outcomes
Primary Outcomes
Evaluation of new software in MRI vascular imaging
Time Frame: 1 year
New software technology will be utilized to enhance MRI imaging of the vascular regions of the body.
Secondary Outcomes
No secondary outcomes reported
Investigators
William Masch
Principal Investigator
University of Michigan